Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) Other Operating Expenses (2016 - 2023)

Historic Other Operating Expenses for Avricore Health (AVCRF) over the last 11 years, with Q4 2023 value amounting to $257797.0.

  • Avricore Health's Other Operating Expenses rose 414.62% to $257797.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $257797.0, marking a year-over-year decrease of 7069.33%. This contributed to the annual value of $889859.5 for FY2024, which is 1977.63% down from last year.
  • According to the latest figures from Q4 2023, Avricore Health's Other Operating Expenses is $257797.0, which was up 414.62% from $338883.0 recorded in Q3 2023.
  • Avricore Health's Other Operating Expenses' 5-year high stood at $338883.0 during Q3 2023, with a 5-year trough of -$237527.1 in Q3 2019.
  • Moreover, its 3-year median value for Other Operating Expenses was $248903.9 (2019), whereas its average is $187565.0.
  • Per our database at Business Quant, Avricore Health's Other Operating Expenses plummeted by 15340.47% in 2019 and then soared by 13779.32% in 2023.
  • Over the past 3 years, Avricore Health's Other Operating Expenses (Quarter) stood at -$237527.1 in 2019, then surged by 204.21% to $247533.7 in 2022, then increased by 4.15% to $257797.0 in 2023.
  • Its Other Operating Expenses was $257797.0 in Q4 2023, compared to $338883.0 in Q3 2023 and $293236.1 in Q2 2023.